VerifyNow IIb/IIIa Assay

Glycoprotein (GP) IIb/IIIa inhibitors such as ReoPro^® and Integrilin^® are fast acting and powerful inhibitors of platelet aggregation that prevent the binding of platelets to fibrinogen. The VerifyNow^® IIb/IIIa assay utilizes a thrombin receptor activating peptide as an agonist to maximally stimulate the platelet and determine the level of platelet function. Research shows that patients’ response to weight-based dosing varies, and the assay provides clinicians with an accurate assessment of platelet blockade within two minutes from the time of sample collection.

Additional Documentation

Instructions for Use, VerifyNow System (PDF),
Interventional Cardiology Brochure (PDF)

INTENDED USE

The VerifyNow IIb/IIIa Assay is a semi-quantitative, whole blood platelet function assay used to measure glycoprotein (GP) IIb/IIIa receptor blockade in patients treated with abciximab or eptifibatide. VerifyNow IIb/IIIa Assay results should be interpreted in conjunction with other clinical and laboratory data available to the clinician.